Requires certain standards be established for contracts between pharmacy benefits managers and health benefits plans.
Summary
Assembly Bill 5012 would require health benefits plans that cover prescription drugs or pharmacy services and are administered or managed by a pharmacy benefits manager (PBM) to let any pharmacy participate as a network pharmacy if it meets the plan’s standard contract terms and conditions. The bill does not set the exact contract terms itself; instead, it directs that those terms and conditions be “reasonable and relevant,” as determined by the Commissioner of Banking and Insurance.
To guide that determination, the commissioner must consider current network pharmacy contract terms and whether reimbursement and dispensing fees are sufficient to cover ingredient costs and operational costs. The bill also authorizes the commissioner to adopt implementing regulations under the Administrative Procedure Act. The measure would take effect on the first day of the thirteenth month after enactment and would apply to PBM contracts entered into or renewed on or after enactment.
Impact
The bill would supplement New Jersey’s existing law governing pharmacy benefits managers and health benefits plans by adding state standards for network pharmacy contract terms. In practice, it would limit PBM and health plan discretion in excluding pharmacies from networks by requiring participation for any pharmacy that satisfies the standard terms, subject to oversight by the Commissioner of Banking and Insurance. It could affect reimbursement practices, dispensing fees, and network access for retail, independent, and other pharmacies, while also creating a regulatory framework for evaluating whether contract terms are commercially reasonable.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the overall sentiment appears supportive of pharmacy access and fairer contracting standards, with the bill framed as a consumer- and provider-protection measure. The sponsor’s approach suggests concern that existing PBM contract practices may not adequately cover pharmacy costs or may impose unreasonable terms. No formal vote history or transcript record is available here to show organized opposition or amendment activity.
Contention
The main point of contention is likely to be the balance between pharmacy access and PBM/health plan contracting flexibility. Supporters would likely favor broader network participation and scrutiny of reimbursement levels, especially for independent pharmacies that argue fees do not cover ingredient and operating costs. Opponents, if any, would likely argue that the bill could interfere with negotiated network standards, increase plan costs, or reduce PBM leverage in managing drug spending. The commissioner’s authority to define what is “reasonable and relevant” would also be a likely focus of debate.
Commissioner of human services selection of a state pharmacy benefit manager through procurement requirement provision, commissioner of human services entrance into a master contract with the state pharmacy benefit manager requirement provision, and program authority and eligibility requirements specification provision
Commissioner of human services required to select a state pharmacy benefit manager through procurement, commissioner required to enter into a master contract with the state pharmacy benefit manager, program authority and eligibility requirements specified, and report required.
Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.